These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A cross-sectional study of vitamin D and insulin resistance in children. Kelly A, Brooks LJ, Dougherty S, Carlow DC, Zemel BS. Arch Dis Child; 2011 May; 96(5):447-52. PubMed ID: 21335626 [Abstract] [Full Text] [Related]
6. Pre-Diabetics with Hypovitaminosis D Have Higher Risk for Insulin Resistance. Nur-Eke R, Özen M, Çekin AH. Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115227 [Abstract] [Full Text] [Related]
7. Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients. Ursini F, Grembiale A, Naty S, Grembiale RD. Clin Rheumatol; 2014 Dec 01; 33(12):1759-64. PubMed ID: 24005838 [Abstract] [Full Text] [Related]
10. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Alemzadeh R, Kichler J, Babar G, Calhoun M. Metabolism; 2008 Feb 01; 57(2):183-91. PubMed ID: 18191047 [Abstract] [Full Text] [Related]
12. Identifying the threshold for vitamin D insufficiency in relation to cardiometabolic markers. Tepper S, Shahar DR, Geva D, Avizohar O, Nodelman M, Segal E, Ish-Shalom S. Nutr Metab Cardiovasc Dis; 2014 May 01; 24(5):489-94. PubMed ID: 24418378 [Abstract] [Full Text] [Related]
14. Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. Clemente-Postigo M, Muñoz-Garach A, Serrano M, Garrido-Sánchez L, Bernal-López MR, Fernández-García D, Moreno-Santos I, Garriga N, Castellano-Castillo D, Camargo A, Fernández-Real JM, Cardona F, Tinahones FJ, Macías-González M. J Clin Endocrinol Metab; 2015 Apr 01; 100(4):E591-5. PubMed ID: 25706239 [Abstract] [Full Text] [Related]
16. 25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects. De Pergola G, Martino T, Zupo R, Caccavo D, Pecorella C, Paradiso S, Silvestris F, Triggiani V. Endocr Metab Immune Disord Drug Targets; 2019 Apr 01; 19(6):838-844. PubMed ID: 30666920 [Abstract] [Full Text] [Related]